Crystalline particles of salts of glutamic acid N,N-diacetic acid
US-2015353475-A1 · Dec 10, 2015 · US
US9815773B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9815773-B2 |
| Application number | US-201314649273-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 12, 2013 |
| Priority date | Dec 14, 2012 |
| Publication date | Nov 14, 2017 |
| Grant date | Nov 14, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to glutamic acid N,N-diacetic acid (GLDA) of the formula GLDA-Y m H n , wherein m is less than 0.5, n+m=4, Y is a monovalent cation that is not a proton, in the form of crystals, a process to make these crystals, and their uses, in particular in detergent compositions.
Opening claim text (preview).
The invention claimed is: 1. Glutamic acid N,N-diacetic acid (GLDA) of the formula GLDA-Y m H n , wherein m is less than 0.5, n+m=4, Y is a monovalent cation that is not a proton, in the form of crystals. 2. GLDA-Y m H n according to claim 1 , wherein m is about 0. 3. GLDA-Y m H n according to claim 1 , wherein the GLDA-Y m H n comprises L-GLDA-Y m H n to D-GLDA-Y m H n in a range of from 100:0 to 50:50 (L:D). 4. Process to prepare glutamic acid N,N-diacetic acid (GLDA) of the formula GLDA-Y m H n , wherein m is less than 0.5, n+m=4, Y is a monovalent cation that is not a proton, in the form of crystals, the process, comprising: a first step of providing an aqueous solution of GLDA or a salt thereof, a second step of ensuring that the pH of the aqueous solution is below 1.8, and a third step of allowing the aqueous solution to crystallize, wherein the aqueous solution that is allowed to crystallize contains at least 15 wt % of GLDA-Y m H n on total solution. 5. Process according to claim 4 , wherein the pH of the second step is in the range of between 1.0 and 1.7. 6. Process according to claim 4 , wherein the second step includes a concentrating step that is carried out until the solution has a concentration of equal to or more than 15 wt % to up to or equal to 80 wt %, of GLDA-Y m H n based on the weight of the aqueous solution. 7. Process according to claim 4 , wherein the aqueous solution that is allowed to crystallize in the third step contains at least 75 wt % of GLDA-Y m H n based on the total organic compounds. 8. Process according to claim 4 , wherein the second step comprises a racemization step. 9. Process according to claim 4 , wherein the third step comprises crystallization accomplished by one or more steps selected from the group consisting of allowing the solution to stand until the solution crystallizes, cooling, and seeding. 10. Process according to claim 4 , wherein the third step comprises spraying the aqueous solution of the second step on seeding crystals. 11. Process according to claim 4 , wherein the third step is performed at a temperature of equal to or below 30° C. 12. Process according to claim 4 , wherein the process is a continuous process. 13. Detergent compositions containing glutamic acid N,N-diacetic acid (GLDA) of the formula GLDA-Y m H n , wherein m is less than 0.5, n+m=4, Y is a monovalent cation that is not a proton, in the form of crystals, and further comprising at least one component selected from the group consisting of cleaning additives, silicates, carbonates, bicarbonates, antiscaling additives, builders, protective colloids, chelating agents, surfactants, inorganic acids, organic acids, and corrosion inhibitors. 14. Pharmaceutical preparations containing glutamic acid N,N-diacetic acid (GLDA) of the formula GLDA-Y m H n , wherein m is less than 0.5, n+m=4, Y is a monovalent cation that is not a proton, in the form of crystals, and further comprising a pharmaceutically acceptable carrier. 15. Process according to claim 4 wherein the aqueous solution that is allowed to crystallize in the third step contains GLDA-Y m H n in a weight ratio of GLDA-Y m H n :inorganic compounds of higher than 1:1. 16. Process according to claim 7 wherein the aqueous solution that is allowed to crystallize in the third step contains GLDA-Y m H n in a weight ratio of GLDA-Y m H n :inorganic compounds of higher than 1:1.
Amino carboxylic acids · CPC title
Crystallisation · CPC title
Crystalline forms, e.g. polymorphs · CPC title
having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid · CPC title
performed by spraying · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.